AU2012201428B2 — Compositions comprising azelastine and methods of use thereof
Assigned to Meda Pharmaceuticals Inc · Expires 2013-08-22 · 13y expired
What this patent protects
The present invention provides a pharmaceutical composition 5 comprising azelastine, or a pharmaceutically acceptable salt or ester thereof, at a concentration of about 0.005% to about 5.0% by weight, and one or more pharmaceutically acceptable carriers or excipients, wherein at …
USPTO Abstract
The present invention provides a pharmaceutical composition 5 comprising azelastine, or a pharmaceutically acceptable salt or ester thereof, at a concentration of about 0.005% to about 5.0% by weight, and one or more pharmaceutically acceptable carriers or excipients, wherein at least one of said pharmaceutically acceptable carriers or excipients is a taste-masking agent that masks the taste of said azelastine or salt or ester thereof such that the sensation 10 of a bitter taste by a patient caused by administration of said pharmaceutical composition to said patient is reduced or eliminated, and wherein at least one of said pharmaceutically acceptable carriers or excipients is sucralose.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.